Skip to content

This study is done to compare the lignocaine in the nebulaization(inhalational) form and lignocaine in the spray form for decreasing the response that is increased blood pressure and heart rate to endotracheal intubation in patients undergoing elective surgery

Comparative Evaluation of Lignocaine Nebulization versus Lignocaine Spray for Attenuation of Pressor Response to Endotracheal Intubation in Patients Undergoing Elective Surgery - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099627
Enrollment
80
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nebulized Lignocaine: Lignocaine nebulized in dose of 1.5mg/kg of 4% lignocaine given via nebulizer over 10 minutes given once before intubation Control Intervention1: Lignocaine spray:

Sponsors

AIMSR Bathinda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 1 and 2, elective surgeries under general anesthesia requiring endotracheal intubation

Exclusion criteria

Exclusion criteria: Known allergy to lignocaine, anticipated difficult airway, cardiovascular or cerebrovascular disease, any recent respiratory infection or disease, use of beta blocker or autonomic drugs, pregnant/ lactating mother

Design outcomes

Primary

MeasureTime frame
Mean and proportion of hemodynamic responseTimepoint: immediately, at 1,3,5,7,10 min after intubation

Secondary

MeasureTime frame
Percentage and proportion of rate of complications ( bronchospasm, lignocaine toxicity, allergic reaction)Timepoint: During and after intubation

Countries

India

Contacts

Public ContactDr Garima Jindal

Adesh Institute of Medical Sciences and Research, BATHINDA

garimajindal90@gmail.com9646486062

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026